In Brief
INTRODUCTION
The eukaryotic target of rapamycin complex 1 (TORC1) is a homeostatic controller of cell growth that adjusts anabolic and catabolic processes to diverse environmental signals, and aberrant mammalian TORC1 (mTORC1) signaling contributes to the progression of human diseases such as cancer and diabetes (Albert and Hall, 2015; Eltschinger and Loewith, 2016; Saxton and Sabatini, 2017) . Amino acids are important signals that control TORC1 function via the conserved, heterodimeric Rag family of GTPases (i.e., yeast Gtr1 combined with Gtr2 or mammalian RagA or RagB combined with RagC or RagD) (Binda et al., 2009; Jewell et al., 2013; Kim et al., 2008; Sancak et al., 2008; Sancak and Sabatini, 2009) . Rag GTPase heterodimers stimulate TORC1 when they contain GTP-loaded Gtr1/RagA/B and GDP-loaded Gtr2/RagC/D, a configuration that is promoted in part by the GTPase activating protein (GAP) complex Lst4-Lst7 that acts on Gtr2 or the orthologous FNIP1/2-Folliculin (FLCN) complex that acts on RagC/D (Pé li- Petit et al., 2013; Tsun et al., 2013) . How amino acids activate TORC1 through these GAP complexes is currently not known (Hatakeyama and De Virgilio, 2016) .
Whereas much attention has been focused on the mechanisms by which amino acids activate (or by which their absence inactivates) the Rag GTPase-TORC1 branch (Powis and De Virgilio, 2016; Saxton and Sabatini, 2017) , recent data indicate the presence of additional regulatory layers such as feedback control loops that allow cells to rapidly and dynamically adjust TORC1 activity to changing levels of extracellular amino acids. In mammalian cells, for instance, amino acid-mediated stimulation of the RagA-mTORC1 interaction (and consequently lysosomal membrane recruitment and activation of mTORC1 by Rheb; Saxton and Sabatini, 2017) is likely attenuated by a negative feedback through Skp2-dependent RagA ubiquitination, which recruits GATOR1 to prevent mTORC1 hyperactivation (Jin et al., 2015) . Because amino acid stimulation results in transient, Gtr1-dependent hyperactivation of vacuolar membrane-resident TORC1 in cells pregrown on nitrogen-poor media (Stracka et al., 2014) , an analogous mechanism may also exist in yeast. In addition, alternative feedback circuits may also act through the Lst4-Lst7 GAP complex, which exhibits only a short-lived preference for Gtr2-binding following re-stimulation of cells with glutamine (Pé li-Gulli et al., 2015) .
Here, we report on our finding that Lst4 is a bona fide target of TORC1 in yeast and that the TORC1-mediated phosphorylation events on Lst4 serve to disperse the Lst4-Lst7 GAP complex from the vacuolar membrane to attenuate its stimulatory effects on Gtr2 and consequently TORC1 itself in glutamine-fed cells. Replacement of Lst4 residues phosphorylated by TORC1 with alanines results in constitutive vacuolar-membrane recruitment of Lst4-Lst7, which causes TORC1 hyperactivation in glutaminestimulated cells and growth defects when cells are cultivated on nitrogen-poor media. Conversely, an Lst4 variant mimicking its TORC1-phosphorylated state, despite being fully capable of forming a functional GAP complex with Lst7, is unable to deliver the complex to the vacuolar membrane and fails to mediate amino acid-dependent TORC1 activation. Thus, our study identifies a physiologically relevant negative feedback mechanism that restricts TORC1 signaling upon sustained glutamine stimulation.
RESULTS AND DISCUSSION
The Intra-DENN Loop Is Necessary and Sufficient for Regulated Vacuolar Membrane Targeting of Lst4 We previously observed that the Lst4-Lst7 heterodimer, like mammalian FNIP1/2-FLCN, clusters at and is released from the vacuolar membrane upon amino acid starvation and refeeding, respectively (Pé li-Gulli et al., 2015; Petit et al., 2013; Tsun et al., 2013) . To address the mechanistic basis of this dynamic regulation of the Lst4-Lst7 complex localization, we initially studied the potential role in this process of the unstructured loop within the DENN (differentially expressed in normal and neoplastic cells) domain of Lst4 (encompassing amino acids 400-600 of Lst4 and referred to as Lst4 loop hereafter), which splits the Lst7-interacting DENN domain of Lst4 into two halves (Pacitto et al., 2015) ( Figure 1A ). Like Lst4-ENVY (or Lst4-GFP; see Pé li-Gulli et al., 2015) , the Lst4 loop -GFP construct localized mainly within the cytoplasm of exponentially growing cells, was rapidly recruited to the vacuolar membrane upon starvation of cells for amino acids, and dispersed back to the cytoplasm upon refeeding of cells with glutamine, which is specifically potent for that matter ( Figure 1B ). An Lst4 ENVY-fusion protein lacking the Lst4 loop region (Lst4 Dloop -ENVY), in contrast, remained constitutively cytoplasmic in similar experiments, indicating that the Lst4 loop is both necessary and sufficient to mediate the amino acid starvation-induced vacuolar membrane recruitment of Lst4. Of note, control co-immunoprecipitation experiments revealed that the Lst4 loop was not required for Lst4 to associate with Lst7 ( Figure 1C ), as also described earlier (Pacitto et al., 2015) . Combined with the fact that Lst7 depends on Lst4 for its vacuolar membrane recruitment (Pé li-Gulli et al., 2015) , the Lst4 loop appears therefore to primarily function in dynamically regulating the localization, but not the Gtr2 GAP function per se (see also below), of the entire Lst4-Lst7 complex. Previously published data suggested that TORC1 antagonizes the vacuolar enrichment of the Lst4-Lst7 complex by a mechanism that remained unexplored (Pé li-Gulli et al., 2015) . We suspected therefore that TORC1 might exert its effect on the localization of Lst4-Lst7 by regulating (directly or indirectly) the function of the Lst4 loop . In support of this idea, we found interventions that reduce TORC1 activity, such as individual or combined loss of Lst4 and Lst7, combined loss of Gtr1 and Gtr2, and rapamycin treatment to trigger the enrichment of the Lst4 Mass spectrometric analysis of Lst4, which has been phosphorylated in vitro by purified TORC1, identified four different phosphopeptides (P1-4) with 12 potentially phosphorylated Ser (S)/Thr (T) residues (arrowheads; see Table S3 ). The 12 Ser/ Thr residues that were mutated to Ala in the Lst4 -V5 (+) were grown exponentially in SC, and the respective extracts were assayed by immunoblot analysis using anti-Lst4-pSer 523 and anti-V5 antibodies.
(E) Lst4-ENVY was immunoprecipitated from exponentially growing lst4D cells and then treated (+), or not (-), with l-phosphatase (l-PPase), which was (+), or was not (-), inactivated by heat (65 ; 30 min) in the presence of EDTA prior to use. Immunoprecipitates were analyzed by immunoblotting using anti-Lst4-pSer 523 and anti-GFP antibodies.
(F) Lst4 phosphorylation on Ser 523 (Lst4-pSer 523 ) mirrors TORC1 activation and requires the presence of Lst7. lst4D or lst4D lst7D strains expressing plasmid-encoded Lst4-V5 were grown exponentially in SC (EXP) and then treated with rapamycin (RAP) or cycloheximide (CHX) for 30 min. Lst4-pSer 523 and Sch9-pThr 737 were analyzed as in (D) and ( ( Figures 1D and 1E ). The expression of the hyperactive TOR1 A1957V allele , in contrast, dispersed the Lst4 loop -GFP from the vacuolar membrane in gtr1/2D cells ( Figure 1F ). The vacuolar membrane recruitment of the Lst4 loop -GFP occurs therefore independently of the presence of Lst4-Lst7 or Gtr1-Gtr2 and is negatively regulated by TORC1.
The Lst4
loop Harbors Multiple TORC1 Phosphorylation Sites Phostag gel electrophoresis separated Lst4-ENVY from extracts of exponentially growing wild-type cells into two roughly equal populations of fast and slowly migrating isoforms ( Figure 2A ). The levels of the latter, which we assumed corresponded to hyperphosphorylated variants of Lst4-ENVY, closely correlated with TORC1 activity, being barely detectable in rapamycintreated and amino acid-starved cells but rapidly induced upon readdition of glutamine to starved cells ( Figure 2A ). To test whether Lst4 is a direct substrate of TORC1, a model we deemed feasible on the basis of both our present results and the reported spatial proximity of Lst4 and TORC1 at the vacuolar membrane (Binda et al., 2009; Pé li-Gulli et al., 2015; Sturgill et al., 2008) , we asked whether Lst4 could be a substrate of TORC1 in vitro. Indeed, TORC1 (purified from yeast) phosphorylated recombinant Lst4 (co-purified with Lst7) in the absence but not in the presence of the ATP-competitive TOR inhibitor Torin2 (Liu et al., 2013) (Figure 2B ). Mass spectrometry (MS) analysis of the respective phosphorylated Lst4 protein allowed us to identify 4 non-overlapping phosphopeptides covering neighboring amino acid stretches within the intra-DENN loop of Lst4 with 12 potential phospho-Ser/Thr residues (see Table S3 ), many of which appeared to be conserved in closely related yeast species ( Figure 2C ). Because TORC1 was unable to phosphorylate in vitro an Lst4
12A variant in which these 12 Ser/Thr residues were substituted with Ala ( Figure 2B ), these 12 residues encompass the majority of residues in Lst4 that are modified by TORC1. To determine whether TORC1 also phosphorylates Lst4 in vivo, we used antibodies that recognized 1 of these 12 residues in Lst4 (i.e., Ser 523 ) specifically in its phosphorylated state ( Figures  2D and 2E) . Accordingly, we found that rapamycin-mediated TORC1 inhibition abolished whereas cycloheximide-mediated TORC1 activation (Binda et al., 2009) Figure 2F ). In addition, physiological interventions such as starvation for amino acids and glutamine refeeding also decreased and induced, respectively, both Lst4-pSer 523 and Sch9-pThr 737 levels with similar dynamics ( Figure 2G ). Moreover, glutamine refeeding failed to stimulate Lst4-Ser 523 phosphorylation in the presence of rapamycin and did not significantly alter the levels of Lst4 (Figures S1A and S1B).
Although our in vitro and in vivo experiments pinpointed Lst4 as a direct TORC1 target, we considered it still formally possible that TORC1 controls Lst4 phosphorylation indirectly via Sch9. To address this point, we performed additional control experiments using a strain that expressed an ATP analog (1NM-PP1) sensitive Sch9 as variant ). Because of the hypomorphic nature of this mutant allele , exponentially growing cells of the respective strain showed decreased basal phosphorylation levels of the Sch9 target Maf1 (i.e., lower levels of the slowly migrating, hyperphosphorylated Maf1 isoforms; compare lanes 3 and 9 in Figure 2H ) that could be further reduced by 1NM-PP1 treatment ( Figure 2H, lanes 10-12) . Remarkably, however, sch9 as cells exhibited strongly increased basal levels of both Lst4-pSer 523 and Sch9-pThr 737 that were even further boosted by 1NM-PP1 treatment ( Figure 2H , lanes 10-12). These results not only imply that Sch9 downregulation triggers TORC1 activation via a hitherto undescribed feedback mechanism but also exclude the involvement of Sch9 in direct phosphorylation of Lst4 (see also Figure S2 ). All of our data combined therefore confirm Lst4 as a bona fide target of TORC1.
Lst4 and Lst7 depend on each other for their assembly on the vacuolar membrane (Pé li-Gulli et al., 2015) . On the basis of our present observations and recent structural studies of Lst4 (Pacitto et al., 2015) , this is likely explained by the fact that Lst7 binds to and consequently reunites the separated parts of the Lst4 split DENN domain, thereby also ensuring the proper folding of the intra-DENN loop of Lst4, which drives the joint recruitment of Lst4 and Lst7 to the vacuolar membrane ( Figure 1A ). Our results therefore predicted that loss of Lst7 should deprive the vacuolar membrane-resident TORC1 of its potential to gain access to and phosphorylate Lst4. This was indeed the case, as we could not detect any phosphorylation of Lst4-Ser 523 in the absence of Lst7, while TORC1 was still able, albeit with reduced activity as expected, to phosphorylate Sch9-Thr 737 in the same strain ( Figure 2F ). ) that our mass spectrometry analyses identified as the most probable TORC1-dependent phosphorylation sites within Lst4 ( Figure 2C ). In line with our previous results (Pé liGulli et al., 2015) , amino acid starvation (or rapamycin treatment) rapidly provoked a strong enrichment of Lst4-ENVY at the vacuolar membrane, which was reversed in starved cells when refed with glutamine ( Figure 3A) . Under the same conditions, Lst4
TORC1 Phosphorylation Sites Critically Control Lst4 Localization
12A -ENVY was found constitutively enriched at, while Lst4 5D was invariably absent from the vacuolar membrane (Figure 3A) . Importantly, both variants Lst4 12A and Lst4 5D associated normally with Lst7 within cells ( Figure 3B ). Moreover, they dictated the localization of Lst7, as Lst7-GFP was constitutively tethered to the vacuolar membrane in Lst4 12A -expressing cells, while it was unable to reach the vacuolar membrane 1NM-PP1 ATP analog-sensitive sch9 as allele (lst4D sch9 as ) co-expressed (+), or not (-), Lst4-V5 and the Sch9 substrate Maf1-HA 3 from plasmids. Cells were grown exponentially (EXP) in SC and then subjected (+), or not (-), to rapamycin (RAP) and/or 1NM-PP1 treatments for the indicated times. Lst4-pSer 523 , Lst4-V5, Maf1-HA 3 , Sch9-pThr 737 , and Sch9 were monitored by immunoblot analysis using anti-Lst4-pSer 523 , anti-V5, anti-HA 3 , anti-Sch9-pThr 737 , and anti-Sch9
antibodies, respectively. P, phosphorylated isoforms of Maf1-HA 3 . See also Figure S2 .
even in rapamycin-treated, Lst4 5D -expressing cells ( Figure 3C ).
Interestingly, all heterodimeric variants normally stimulated the GTPase activity of Gtr2 when assayed in vitro ( Figure 3D ).
Within cells, however, glutamine refeeding expectedly overstimulated the interaction between Lst4 12A and GTP-locked Gtr2 Q66L , while Lst4 5D was significantly compromised in its 12A (12A), and Lst4 5D (5D) stimulate the GTPase activity of Gtr2 to a similar extent when combined with Lst7. Purified GST-Gtr1 Q65L -His 6 /GSTGtr2 (200 nM) were pre-loaded with (a-32 P) GTP and incubated for 20 min in the presence (WT, +; 12A, +; 5D, +; lanes 3-5) or absence (-, -; lane 2) of the different Lst4-Lst7 heterodimers (each 100 nM). The extent of (a -32 P) GTP hydrolysis to (a-32 P) GDP was measured by thin-layer chromatography (TLC), of which one representative autoradiograph is shown. In control experiments, (a-32 P) GTP was incubated alone (lane 1) or only together with the Lst4-Lst7 heterodimer variants (lanes [6] [7] [8] . Notably, Lst4-Lst7, Lst4 12A -Lst7, and Lst4 5D -Lst7 did not significantly differ in their capacities to enhance the GTP hydrolytic activity of Gtr2, as the respective GAP-mediated fold increase of GTP hydrolysis was 31.5 ± 2.7 for Lst4-Lst7, 38.5 ± 12.0 for Lst4 12A -Lst7, and 41.4 ± 16.6 for Lst4
5D
-Lst7 (n = 3; ±SD). (E) Exponentially growing lst4D gtr1D gtr2D and gtr1D gtr2D cells expressing the Lst4-ENVY variants and GFP-Rpl25 (control), respectively, as well as Gtr1-HA 3 and Gtr2 Q66L -V5, were starved for amino acids (5 min; -) and then restimulated with glutamine (4 min; Gln; +). Lysates (input) and anti-GFP immunoprecipitates (IP: anti-GFP) were analyzed by immunoblotting using anti-GFP and anti-V5 antibodies. The corresponding interactions with wild-type Gtr2 were similar to, but overall weaker than, the ones with the preferred Lst4 substrate Gtr2 Q66L (Pé li-Gulli et al., 2015; data not shown).
capacity to bind Gtr2 Q66L under the same conditions (Figure 3E ). Taken together, our results are all consistent with a model in which TORC1-dependent phosphorylation of Lst4 primarily serves to dislodge the Lst4-Lst7 GAP complex from the vacuolar membrane. , and Lst4 5D exhibit distinct TORC1 activation properties in vivo. Cells (lst4D) expressing, or not, the indicated Lst4-ENVY variants from their genomes were grown and tested for their TORC1 activities as in Figure 2A . Relative TORC1 activities were determined as the ratio of Sch9-pThr 737 /Sch9 in lst4D LST4-ENVY (WT), lst4D, lst4D 
TORC1-Mediated Control of Lst4 Localization Is Part of a Negative Feedback Mechanism
Given that the Lst4-Lst7 complex is critical for amino acid-dependent TORC1 activation, we reasoned that the aberrant subcellular localization of Lst4 12A or Lst4 5D might affect TORC1 activity in vivo. Indeed, the Lst4 12A mutant allele significantly hyperstimulated TORC1 in glutamine-refed cells ( Figure 4A ). Conversely, cells expressing the Lst4 5D allele exhibited, like lst4D cells, a strong defect in TORC1 reactivation when refed with glutamine subsequent to amino acid starvation ( Figure 4A ). As expected on the basis of our in vitro GAP assays ( Figure 3D ), both Lst4 alleles (i.e., Lst4 12A and Lst4
5D
) were equally competent in vivo to reactivate TORC1 upon glutamine refeeding when they were artificially and constitutively tethered to the vacuolar membrane ( Figures 4B and 4C) . Thus, the vacuolar membrane localization of Lst4 (combined with Lst7) is a pivotal process that is required for Rag GTPase-dependent activation of TORC1 by amino acids, and TORC1 inhibits (in a feedback loop) the Lst4-Lst7 Rag GTPase GAP primarily by favoring its dispersal from the surface of the vacuole.
Homeostatic control of TORC1 activity is important for the adaptation of cells to changing environments. Accordingly, a downshift in the quality of the nitrogen source coordinately downregulates TORC1 to induce, for instance, the expression of specific amino acid permeases and catabolic enzymes, and failure to do so (e.g., when cells express hyperactive Rag GTPases) results in cell proliferation defects on nitrogen-poor media (Binda et al., 2009; Neklesa and Davis, 2009 ). Consistent with this notion and the observed TORC1 activities in our lst4 mutants ( Figure 4A ), we found lst4 12A cells, but not wild-type or lst4 5D cells, to exhibit a moderate but statistically significant cell proliferation defect when grown on the poor nitrogen source urea, while all strains grew equally well on a preferred nitrogen source (i.e., a mixture of all amino acids; Figures 4D and 4E) . Moreover, loss of the Gtr1 GAP Iml1, which causes Gtr1 to be predominantly in its TORC1-activating GTP-bound state , caused a similar growth defect when cells were grown on urea ( Figure 4D) . Remarkably, the combination of iml1D (sustaining Gtr1 GTP )
and lst4 12A (sustaining Gtr2 GDP ) caused a dramatic synthetic growth defect that rendered cells unable to grow on urea, while they grew normally on amino acid-rich medium ( Figures 4D and  4E ). Appropriate feedback inhibition of the Lst4-Lst7 module by TORC1 is therefore part of a physiologically relevant adaptation program.
Taken together, our work advocates a model in which amino acid limitation triggers, through a still largely elusive mechanism, TORC1 downregulation, thereby favoring dephosphorylation and recruitment of the GAP complex Lst4-Lst7 to the vacuolar membrane ( Figure 4F ). In addition to being tethered proximally to Gtr2, the Lst4-Lst7 GAP further requires the presence of amino acids to be able to act on Gtr2 ( Figure 4F, I ), which then, in association with Gtr1, stimulates TORC1 ( Figure 4F, II) . Subsequent feedback inhibition of Lst4-Lst7 ( Figure 4F, III) , as revealed in this study, is a central element that secures the dynamic adjustment of TORC1 activity in response to amino acids. Further refinement of this model will undoubtedly depend on the identification of the protein(s) that dock Lst4 to the vacuolar membrane ( Figure 4F , question mark). While we deem it possible that such a protein(s) may also be implicated in local amino acid-driven activation of the Lst4-Lst7 complex toward Gtr2, we speculate that the multiple TORC1 target residues in Lst4 might additively dictate the recognition of such a protein(s) and hence provide an additional regulatory layer to fine-tune graded TORC1 feedback responses. Finally, human FNIP1/2, like Lst4, contain a split DENN domain (Pacitto et al., 2015) , and FLCN reportedly concentrates at the lysosomal surface upon mTORC1 inactivation in a human retinal pigment epithelial cell line (ARPE-19) (Martina et al., 2014) , indicating that mTORC1 may use a feedback mechanism in higher eukaryotes that is analogous to the one in yeast.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Growth Conditions Saccharomyces cerevisiae strains and plasmids used in this study are listed in Tables S1 and S2, respectively. Exclusively prototrophic yeast strains were used throughout this study. Unless stated otherwise, yeast cells were pregrown in synthetic dropout (SD; 0.17% yeast nitrogen base, 0.5% ammonium sulfate [AS], 0.2% dropout mix [USBiological] , and 2% glucose) medium to maintain plasmids, spun and diluted in synthetic complete medium (SC; SD with all amino acids, but without AS), starved of amino acids and restimulated with 3 mM glutamine as previously reported (Pé li-Gulli et al., 2015) . Rapamycin (LC Laboratories), cycloheximide (Sigma), and 1 NM-PP1 (Cayman Chemicals) were used at 200 ng ml
À1
, 25 mg ml À1 , and 200 nM, respectively, for the times indicated.
In Vivo and In Vitro TORC1 Activity Assays In vivo TORC1 activity was monitored as previously described (Pé li-Gulli et al., 2015) , making use of phosphospecific anti-Sch9-pThr 737 and anti-Sch9 antibodies (GenScript) to probe endogenous Sch9. For in vitro kinase assays, TORC1 was TAP-purified from a Tco89-TEV-TAP-expressing yeast strain grown in YPD and treated for 10 min with cycloheximide. The extraction buffer (50 mM HEPES/NaOH [pH 7.5], 5 mM CHAPS, 400 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 400 mM Pefabloc, 13 Roche complete protease inhibitor-EDTA) was used to resuspend cells that were subjected to cryogenic disruption with an MM 400 Mixer Mill (Retsch). The cleared lysate was incubated with IgG-coupled Dynabeads (Dynabeads M-270 Epoxy; Invitrogen) for 2 hr at 4 C. After washes, the TORC1 complex was eluted using 5% TEV protease. Recombinant His 6 -tagged Lst4 variants (600 ng/30 ml reaction) were co-purified with His 6 -tagged Lst7 and used as in vitro substrates in TORC1 kinase reactions performed according to Urban et al. (2007) . Briefly, reactions were performed in kinase buffer (50 mM HEPES/NaOH [pH 7.5], 5 mM CHAPS, 400 mM NaCl, 0.5 mM DTT, phosphatase inhibitors), started by adding the ATP Mix (4.2 mM MgCl 2 , 300 mM ATP, and 3.3 mCi [g-32 P]-ATP [Hartmann Analytic, SRP-501]) and stopped by adding SDS-PAGE sample buffer. Proteins were separated by SDS-PAGE, stained with Sypro Ruby (Sigma), and analyzed using a phosphorimager (Typhoon FLA 9500; GE Healthcare).
Mass Spectrometry Analyses
Mass spectrometric measurements were performed on a Q Exactive Plus mass spectrometer coupled to an EasyLC 1000 (Thermo Fisher Scientific). Prior analysis phosphopeptides were enriched by TiO 2 . The mass spectrometry raw data files were analyzed using MaxQuant software (Cox and Mann, 2008) , version 1.4.1.2, using a Uniprot S. cerevisiae database from March 2016 containing common contaminants such as keratins and enzymes used for in-gel digestion.
Miscellaneous GAP assays were performed as previously detailed (Pé li-Gulli et al., 2015) . Co-immunoprecipitation and fluorescence microscopy experiments were also carried out as described before . Phosphorylated forms of tagged-Lst4 were detected by electrophoresis on a 6% SDS-PAGE gel containing 20 mM Phos-tag (Wako) followed by immunoblotting with anti-GFP antibodies (Roche) or by classical SDS-PAGE and immunoblotting using antiLst4-pSer 523 antibodies generated by GenScript and anti-V5 antibodies (Thermo Fisher Scientific). A standard protocol was applied to in vitro dephosphorylate immunoprecipitated Lst4-ENVY with l-phosphatase (New England Biolabs). Figure expressing plasmid-encoded Lst4-V5 were treated as in Figure 2G , except that rapamycin (200 ng ml -1 ) was added at the beginning of the amino acid starvation and maintained throughout the glutamine restimulation period.
Supplemental Figures
(B) Amino acid starvation and glutamine refeeding do not significantly affect Lst4-V5 levels. Cells (as in [A] ) were treated as in Figure 2G , including additional sampling time points up to 60 min following glutamine refeeding. Representative anti-V5 and anti-Adh1 immunoblots are shown together with respective values of the Lst4-V5 levels that were calculated as the mean ratio of Lst4-V5/Adh1 (n =3; ± SD) and normalized to the respective ratio in exponentially growing (EXP) cells (set to 1.0). Exponentially growing lst4∆ sch9∆ cells expressing plasmid-encoded Lst4-V5 and Maf1-HA 3 were starved for amino acids and refed with glutamine and analyzed for the phosphorylation levels of Ser 523 in Lst4, for the total levels of Lst4-V5, and, in an additional control, for the extent of hyperphosphorylation of the Sch9 target Maf1-HA 3 (as in Figure 2H ). As judged from the relative levels of the slowly migrating Lst4-V5 versus the respective faster migrating ones, and in line with the results in Figure 2H , loss of Sch9 appeared to result in Lst4 hyperphosphorylation in non-starved cells. Notably, while Maf1-HA 3 migrated in multiple phosphorylated isoforms in exponentially growing cells expressing functional Sch9 ( Figure 2H ), no such isoforms were detected in the absence of Sch9 (neither in exponentially growing nor in glutamine-refed sch9∆ cells). 
Figure S1

